Gameto plans to integrate this meiosis-induction approach with its proprietary ovarian organoid (“ovaroid”) platform to ...

Modern therapeutics are shifting from their reliance on small molecules to biologics produced by cultured cells. The development and production of those biologics increasingly rely on computationally ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic biology sectors, driven by advancements in molecular cloning, drug discovery, ...